INTRODUCTION
Diabetes mellitus is the most commonly encountered health problem worldwide. 1 Studies have shown that 6-8% of the adult population worldwide is diagnosed with diabetes. 2 According to World Health Organization reports, the prevalence of this condition will double by the year 2025. It is the metabolic disorder, which damages target organs and is characterized by chronic hyperglycemia. 3 One of the most common complications associated with diabetes is diabetic foot ulcer (DFU), which accounts for around 20% of hospital admissions around the world. 4, 5 Furthermore, DFUs are one of the most common causes of lower limb amputations, prolonged outpatient care and hospitalization.
It is estimated that about 15% of all the diabetic patients develop foot ulcers during their lifetime. 4, 6 Infection is one of the complications associated with DFUs, and an infected DFU is also the second major cause of amputation. 3 Bacterial colonization occurs in deep tissues once the protective layer of the skin is broken. 1 Therefore, DFUs are highly prone to infections. Once the bacterial infection occurs, it rapidly spreads and leads to severe destruction of tissues that requires subsequent amputation. DFU infections and it is also one of the most adaptable human pathogens responsible for causing a wide range of illnesses. 10 A major threat to public health is the increasing prevalence of antimicrobial resistance which occurs due to excess usage of antibiotics. 11 In 15-30% of DFUs, methicillin-resistant S. aureus (MRSA) are isolated. 12 Different factors are responsible for this resistance but mainly it is due to inappropriate antibiotic treatment and poor hygiene. 6 Infrequent patient contact and follow-up has also contributed to resistance development as they may encourage the clinician to overprescribe. 13 The virulence potential of S. aureus present in DFUs is also a factor, which can contribute to wound severity as these factors enables this pathogen to access and destroy the host tissue.
The aim of the present study was to detect the presence of S. aureus in infected DFUs along with its virulence and antibiotic resistance profiles. An understanding of the pathogenic and antibiotic resistance profiles of S. aureus in DFUs will assist health professionals to manage this ailment more efficiently by using targeted therapy.
Aims and objectives
• To detect the presence of S. aureus in DFU samples using molecular methods • To determine the prevalence of MRSA in DFUs • To determine the virulence profile of S. aureus in DFUs.
METHODS
DFU swab samples were collected from 30 patients at different time points (from March-October 2012) using the Z-swab technique. All swabs were kept at 4°C until transported to the laboratory, whereupon they were stored at −80°C until further analysis.
DNA extraction
DNA was extracted from S. aureus ATCC control strains (ATCC 29213 and USA 300) and patient swabs using an optimised Qiagen protocol as per manufacturer's guidelines.
Detection of S. aureus and its methicillin resistance and virulence determinants in DFUs
The gene for S. aureus speciation was nucA and mecA for methicillin resistance. Virulence gene targets included: Panton-Valentine leukocidin (PVL), alpha toxin, exfoliatin factor A (exfA), fibronectin factor A (fnbA) and fibronectin factor B (fnbB). Primers were selected from previously published studies (Table 1) . After primer optimization, DNA extracted from wound swabs was subjected to individual polymerase chain reaction (PCR) reaction conditions depending on the targeted gene.
PCR reaction for S. aureus (nucA, mecA, PVL, alpha toxin, exfA, fnbA and fnbB) Each 25 µl PCR reaction contained 2 µl of DNA which was added to 23 µl of master mix containing 0.1 µl of Taq polymerase (Roche, Australia), 0.5 µl of dNTPs (Roche, Australia), 0.625 µl each of reverse and forward primers (Table 2 ) (Sigma Aldrich, Australia), 1.5 µl of MgCl 2 (Roche, Australia), 2.5 µl of 10X PCR buffer (Roche, Australia) and 17.15 µl of water (DNAse and RNAse free -Life Technologies, Australia). PCR was performed using the program, including initial denaturation at 95°C for 10 mins, followed by 30 cycles of annealing and extension (72°C for 30 sec). An annealing temperature of 55°C was used for nucA and mecA gene amplification. 60°C was used as an annealing temperature for alpha toxin, fnbA and fnbB genes. exfA gene was amplified using an annealing temperature of 49°C. Final extension was carried out for 5 mins at 72°C. The PCR products were visualized using agarose gel (2%) electrophoresis. Gel images were captured using the GeneSnap program of G: BOX gel documentation system, Syngene Australia.
RESULTS
This study included a total of 30 diabetic patients with DFUs. The concentration of DNA extracted from 223 swab samples ranged from 2 to 80 ng/µl. PCR was used to detect and characterize the commonly detected microbial species S. aureus from DFUs. It was found that 44.8% of DFU swab samples were positive for the nucA gene confirming the presence of S. aureus in these samples. All the S. aureus positive samples were examined further for the presence of MRSA by targeting the mecA gene. 25% of S. aureus positive samples were found to be MRSA. None of the S. aureus positive samples were positive for PVL. The alpha toxin gene was detected in 85% of the S. aureus positive samples, and the exfA gene was detected in 61% of the S. aureus positive samples. For the fnbA and fnbB genes, 71% and 74% of the S. aureus positive samples were positive for these two genes ( Figure 1 ).
Figure 1: Methicillin resistance and virulence profile
of Staphylococcus aureus present in diabetic foot ulcerations.
DISCUSSION
From the 30 patients recruited, 223 DFU swab samples were analyzed for the presence of S. aureus. The majority of previous studies have documented that S. aureus is the most commonly isolated Gram-positive bacteria from infected DFU. 1,2,12-16 An Indian study showed that S. aureus was present in 21% of a total of 112 samples. 3 Our results show that 66.6% of diabetic patients had S. aureus in their foot ulcers, and 44.8% of all the DFU swab samples were positive for S. aureus. This data are similar to what has been reported previously in a study performed at the Royal Melbourne Hospital in 2009 by Yates et al., however, their study used traditional culture-based methods. 17 S. aureus has a number of virulence factors that facilitates the infection of soft tissues and bones. PVL is one of these virulence traits, and it seems to be associated with severely infected DFUs. 18 In our study, none of the DFU patient samples were positive for PVL. Alpha-toxin is considered to be the most renowned S. aureus toxin and it has cytolytic activity. 19 Its role in DFU infection is not well documented in the literature. We found that this toxin was present in 85% of S. aureus positive DFU swab samples. One of the previous studies have reported that the exfA gene was absent in their DFU samples. 20 In our study, exfA was detected in 61% of the S. aureus positive DFU swab samples. fnbA and fnbB are members of microbial surface components recognizing adhesive matrix molecules family and mediate S. aureus adhesion to the host cell. In our study, fnbA gene was present in 71% of S. aureus positive DFU swab samples and the fnbB gene was present in 74% of S. aureus positive DFU swab samples.
DFUs are found to be increasingly inhabited with MRSA. 21 A major health threat to the hospital and community setting is the increasing frequency of MRSA isolation from DFU. The majority of findings have shown that the prevalence of MRSA among diabetic patients with infected foot ulcers is 15-30%. 2, 22, 23 In the United Kingdom, a study was conducted in which 30% of all cultured DFUs had MRSA. This MRSA colonization was linked to prior antibiotic usage, and it adversely affected the wound healing process. 3 In our study, we have found that 25% of all the S. aureus positive samples were MRSA. This trend is similar to that found by Yates et al. (2009) , who isolated MRSA from 23% of DFUs. The factors predisposing to MRSA infection include chronic duration of DFU and prolonged use of antibiotics. 17 The rationale for targeting only S. aureus in our study is based on its increasing prevalence in DFUs, as described by previously published studies (Table 2 ). Our study reports the prevalence of S. aureus, MRSA and associated S. aureus virulence factors using molecular methods. To the best of our knowledge, this is the first Queensland study which has used molecular methods to characterize the virulence and methicillin resistance traits of S. aureus associated with DFUs.
